Dr. Akash Nanda is director of urologic and hematologic radiation oncology and director of patient safety at the Orlando Health Cancer Institute. A board-certified radiation oncologist, Dr. Nanda is skilled in proton therapy, a type of radiation treatment that uses proton beams to target and shrink tumors. His other specialties include:
- Urologic cancers (prostate, bladder, kidney, testicular)
- Hematologic cancers (lymphomas, plasmacytoma and myeloma)
- Stereotactic body radiation therapy (SBRT) for prostate cancer
- Placement of Space OAR hydrogel, which creates a protective barrier in prostate cancer treatment
- Intensity-modulated radiation therapy (IMRT)
- Targeted radionuclide therapy for advanced prostate cancer
Dr. Nanda’s Training
Dr. Nanda graduated from the MD/PhD program at the Johns Hopkins University School of Medicine in Baltimore, where he also received his doctorate in human genetics and molecular biology. He completed his residency in radiation oncology at the Harvard Radiation Oncology Program and was awarded a resident research grant. He also participated in a prostate brachytherapy fellowship at the Seattle Prostate Institute.
About Dr. Nanda
Dr. Nanda is an associate professor at the University of Central Florida College of Medicine in Orlando, teaching radiation oncology. He also is a principal investigator in a Research and Clinical Trials Program focusing on urologic cancers, and his primary research interests include outcomes analyses and the design of prospective clinical trials for prostate cancer and quality improvement.
Dr. Nanda has presented his research at several national meetings and in numerous peer-reviewed journals. He has one patented biomedical invention.
He is certified in radiation oncology by the American Board of Radiology. Dr. Nanda is a member of the American Society for Radiation and Oncology, American Society of Clinical Oncology, Radiological Society of North America, American Association for Cancer Research and American Medical Association.